These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 15602503)
1. Effects of the mixed mu/kappa opioid nalbuphine on cocaine-induced changes in subjective and cardiovascular responses in men. Mello NK; Mendelson JH; Sholar MB; Jaszyna-Gasior M; Goletiani N; Siegel AJ Neuropsychopharmacology; 2005 Mar; 30(3):618-32. PubMed ID: 15602503 [TBL] [Abstract][Full Text] [Related]
2. Opioid and cocaine combined effect on cocaine-induced changes in HPA and HPG axes hormones in men. Goletiani NV; Mendelson JH; Sholar MB; Siegel AJ; Mello NK Pharmacol Biochem Behav; 2009 Feb; 91(4):526-36. PubMed ID: 18848957 [TBL] [Abstract][Full Text] [Related]
3. Effects of nalbuphine on anterior pituitary and adrenal hormones and subjective responses in male cocaine abusers. Goletiani NV; Mendelson JH; Sholar MB; Siegel AJ; Skupny A; Mello NK Pharmacol Biochem Behav; 2007 Apr; 86(4):667-77. PubMed ID: 17391744 [TBL] [Abstract][Full Text] [Related]
4. Effects of mu-opioid agonists on cocaine- and food-maintained responding and cocaine discrimination in rhesus monkeys: role of mu-agonist efficacy. Negus SS; Mello NK J Pharmacol Exp Ther; 2002 Mar; 300(3):1111-21. PubMed ID: 11861822 [TBL] [Abstract][Full Text] [Related]
5. Effects of mixed-action kappa/mu opioids on cocaine self-administration and cocaine discrimination by rhesus monkeys. Bowen CA; Negus SS; Zong R; Neumeyer JL; Bidlack JM; Mello NK Neuropsychopharmacology; 2003 Jun; 28(6):1125-39. PubMed ID: 12637953 [TBL] [Abstract][Full Text] [Related]
6. Discriminative stimulus effects of nalbuphine in rhesus monkeys. Gerak LR; France CP J Pharmacol Exp Ther; 1996 Feb; 276(2):523-31. PubMed ID: 8632318 [TBL] [Abstract][Full Text] [Related]
7. Influence of buprenorphine, butorphanol and nalbuphine on the initiation of intravenous cocaine self-administration in drug naive mice. Kuzmin AV; Gerrits MA; Zvartau EE; van Ree JM Eur Neuropsychopharmacol; 2000 Dec; 10(6):447-54. PubMed ID: 11115734 [TBL] [Abstract][Full Text] [Related]
8. Effects of gonadal steroid hormone treatments on opioid antinociception in ovariectomized rhesus monkeys. Negus SS; Mello NK Psychopharmacology (Berl); 2002 Jan; 159(3):275-83. PubMed ID: 11862360 [TBL] [Abstract][Full Text] [Related]
9. The mu/kappa agonist nalbuphine attenuates sensitization to the behavioral effects of cocaine. Smith MA; Cole KT; Iordanou JC; Kerns DC; Newsom PC; Peitz GW; Schmidt KT Pharmacol Biochem Behav; 2013 Mar; 104():40-6. PubMed ID: 23305678 [TBL] [Abstract][Full Text] [Related]
10. Interactions between opioids and cocaine on locomotor activity in rats: influence of an opioid's relative efficacy at the mu receptor. Smith MA; Gordon KA; Craig CK; Bryant PA; Ferguson ME; French AM; Gray JD; McClean JM; Tetirick JC Psychopharmacology (Berl); 2003 May; 167(3):265-73. PubMed ID: 12669175 [TBL] [Abstract][Full Text] [Related]
11. The effects of repeated opioid administration on locomotor activity: I. Opposing actions of mu and kappa receptors. Smith MA; Greene-Naples JL; Lyle MA; Iordanou JC; Felder JN J Pharmacol Exp Ther; 2009 Aug; 330(2):468-75. PubMed ID: 19403853 [TBL] [Abstract][Full Text] [Related]
12. Self-Administration of cocaine-opioid combinations by rhesus monkeys: evaluation of the role of mu receptor efficacy using labor supply analysis. Rowlett JK; Rodefer JS; Spealman RD J Pharmacol Exp Ther; 2005 Mar; 312(3):1289-97. PubMed ID: 15550572 [TBL] [Abstract][Full Text] [Related]
13. Enadoline and butorphanol: evaluation of kappa-agonists on cocaine pharmacodynamics and cocaine self-administration in humans. Walsh SL; Geter-Douglas B; Strain EC; Bigelow GE J Pharmacol Exp Ther; 2001 Oct; 299(1):147-58. PubMed ID: 11561074 [TBL] [Abstract][Full Text] [Related]
14. Effects of kappa opioid agonists alone and in combination with cocaine on heart rate and blood pressure in conscious squirrel monkeys. Schindler CW; Graczyk Z; Gilman JP; Negus SS; Bergman J; Mello NK; Goldberg SR Eur J Pharmacol; 2007 Dec; 576(1-3):107-13. PubMed ID: 17707792 [TBL] [Abstract][Full Text] [Related]
15. Additive and subadditive antiallodynic interactions between μ-opioid agonists and N-methyl D-aspartate antagonists in male rhesus monkeys. Cornelissen JC; Steele FF; Rice KC; Nicholson KL; Banks ML Behav Pharmacol; 2018 Feb; 29(1):41-52. PubMed ID: 29239974 [TBL] [Abstract][Full Text] [Related]
16. Antinociceptive effects of monoamine reuptake inhibitors administered alone or in combination with mu opioid agonists in rhesus monkeys. Gatch MB; Negus SS; Mello NK Psychopharmacology (Berl); 1998 Jan; 135(1):99-106. PubMed ID: 9489939 [TBL] [Abstract][Full Text] [Related]
17. Dual κ-agonist/μ-antagonist opioid receptor modulation reduces levodopa-induced dyskinesia and corrects dysregulated striatal changes in the nonhuman primate model of Parkinson disease. Potts LF; Park ES; Woo JM; Dyavar Shetty BL; Singh A; Braithwaite SP; Voronkov M; Papa SM; Mouradian MM Ann Neurol; 2015 Jun; 77(6):930-41. PubMed ID: 25820831 [TBL] [Abstract][Full Text] [Related]
18. Mixed κ/μ partial opioid agonists as potential treatments for cocaine dependence. Bidlack JM Adv Pharmacol; 2014; 69():387-418. PubMed ID: 24484983 [TBL] [Abstract][Full Text] [Related]
19. Comparing the subjective, psychomotor and physiological effects of intravenous nalbuphine and morphine in healthy volunteers. Zacny JP; Conley K; Marks S J Pharmacol Exp Ther; 1997 Mar; 280(3):1159-69. PubMed ID: 9067299 [TBL] [Abstract][Full Text] [Related]